Concepedia

Mark Dedden

MD

Statistics

Publications

4

Citations

103

H-Index

4

Active since

2019

Affiliations

Universitätsklinikum Erlangen(Current)

Friedrich-Alexander-Universität Erlangen-Nürnberg

Mark Dedden is an author at Universitätsklinikum Erlangen specializing in life sciences, immunology, and inflammatory bowel disease.

Publications per year

2019–2023

4

Publications

4

CRISPR-Cas9-mediated genome editing in vancomycin-resistant <i>Enterococcus faecium</i>

Vincent de Maat, Paul B. Stege, Mark Dedden et al. · FEMS Microbiology Letters · 2019 · 37 citations · Full text

, , +14

Residual homing of α4β7-expressing β1 <sup>+</sup> PI16 <sup>+</sup> regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab

Emily Becker, Mark Dedden, Christine M. Gall et al. · Gut · 2021 · 35 citations

, , +17

IL-3 receptor signalling suppresses chronic intestinal inflammation by controlling mechanobiology and tissue egress of regulatory T cells

Karen A.-M. Ullrich, J Derdau, Carsten Baltes et al. · Gut · 2023 · 20 citations · Full text

, , +17

Anti‐β7 integrin treatment impedes the recruitment on non‐classical monocytes to the gut and delays macrophage‐mediated intestinal wound healing

Katrin Sommer, Karin Heidbreder, Mark Dedden et al. · Clinical and Translational Medicine · 2023 · 11 citations · Full text

, , +17

1–4 of 4